PlainPatent
USPTO 2015–2025 USPTO PatentsView US Corporation

Arrien Pharmaceuticals LLC

USPTO PatentsView assignee record - 13 granted patents across 4 technology areas, recorded in grant years 2015–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07D (Heterocyclic Compounds).

RSS updates for this company
Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Arrien ranks #20,766 of 49,997 tracked US assignees by granted-patent volume, with 13 patents across 4 technology areas.

#20,766
of 49,997 US assignees by volume
14th percentile
by Innovation Score (24.1/100)
13.2
avg claims per patent
-82%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R20766 · US Corporation #20,766 · 13 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

  • GRANTS-MICRO 13 grants
  • MID-PACK #20,766/49,997
  • PHOTO-FINISH Armacell Enterprise…
  • CPC-NARROW C07D · 4 areas
  • INNOV-THIN 24.1/100
  • CLAIMS-RICH 13.2 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-DROP -82% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Armacell Enterprise GMBH & Co. KG (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Arrien’s 24.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Arrien

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Arrien's Innovation Score is 24.1/100 (14th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Arrien?

Each dot is one of Arrien’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Arrien’s own 13.2 claims/patent is at or below the 13.7 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Arrien vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 12.912.91313.1 5101520 Granted patents (volume) Avg claims / patent Armacell Enterprise GMBH & Co. KG - 13, 19Armacell Enterpri…Armo Biosciences, Inc. - 13, 18.92Armo BiosciencesArnold Umformtechnik GMBH & Co. KG - 13, 13.69Arnold Umformtech…Aroma System S.R.L. - 13, 8.92Aroma System S R LArtery Technology Company - 13, 13.15Artery TechnologyArtskills, Inc. - 13, 11ArtskillsASM Assembly Systems Singapore PTE. Ltd. - 13, 17.46ASM Assembly Syst…Asset Guard Products Inc. - 13, 18.92Asset Guard Produ…Arrien Pharmaceuticals LLC - 13, 13.23Arrien Pharmaceut…
Arrien vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Arrien's grants concentrate

Arrien Pharmaceuticals LLC is a focused PatentsView assignee: 4 CPC subclasses with 100% of grants classified under C07D (Heterocyclic Compounds). Peak complete grant year is 2016 (3 grants) versus a trough of 1 in 2019. By volume, Arrien sits between Armacell Enterprise GMBH & Co. KG and Asset Guard Products Inc..

Who files at Arrien's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Arrien holds 13 patents at rank #20,725, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Arrien

By rank, the assignees closest to #20,725 in granted patent volume.

Leaders in C07D (Heterocyclic Compounds)

Other assignees with the most granted patents in Arrien's primary technology class.

Arrien's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

24 14th percentile higher than 14% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0.511.522.533.5 2015201620172018201920202021 1
USPTO utility patent grants by year · 2015–2021

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Arrien Pharmaceuticals LLC patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 2 15.4%
2016 3 23.1%
2017 2 15.4%
2018 3 23.1%
2019 1 7.7%
2020 1 7.7%
2021 1 7.7%

Which technologies does Arrien Pharmaceuticals LLC patent most?

Top 4 of 4 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Arrien Pharmaceuticals LLC's patent record in context - here's where to go next.

  • Arrien Pharmaceuticals LLC's lead technology class is C07D (Heterocyclic Compounds), 100% of its portfolio - see every assignee active in that class. Explore C07D
  • Ranked #20,766 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Arrien Pharmaceuticals LLC against Armacell Enterprise GMBH & Co. KG, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 24.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page
  • USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.